We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.19B
AUM Growth
+$8.49M
Cap. Flow
-$236M
Cap. Flow %
-5.63%
Top 10 Hldgs %
9.13%
Holding
691
New
49
Increased
226
Reduced
294
Closed
110

Top Buys

Rank Stock Value
1
G icon
Genpact
G
+$15.7M
2
SN icon
SharkNinja
SN
+$10.3M
3
COLD icon
Americold
COLD
+$8.79M
4
MRCY icon
Mercury Systems
MRCY
+$8.73M
5
OSBC icon
Old Second Bancorp
OSBC
+$7.85M

Sector Composition

Rank Sector Weight
1 Financials 20.3%
2 Industrials 19.06%
3 Healthcare 16.19%
4 Technology 14.12%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAPR icon
526
Capricor Therapeutics
CAPR
$223M
$745K 0.02%
75,019
-78,468
-51% -$829K
CRAI icon
527
CRA International
CRAI
$1.07B
$733K 0.02%
3,910
+333
+9% +$59.5K
ORKA
528
Oruka Therapeutics
ORKA
$6.23B
$728K 0.02%
64,926
-823
-1% -$8.58K
NVEE
529
DELISTED
NV5 Global
NVEE
$717K 0.02%
31,033
-58,915
-65% -$1.18M
RITM icon
530
Rithm Capital
RITM
$5.62B
$702K 0.02%
+62,146
New +$685K
PWP icon
531
Perella Weinberg Partners
PWP
$1.25B
$677K 0.02%
34,839
+2,982
+9% +$52.7K
QRHC icon
532
Quest Resource Holding
QRHC
$29.9M
$629K 0.02%
311,289
+107,107
+52% +$246K
ROIV icon
533
Roivant Sciences
ROIV
$26.1B
$628K 0.02%
55,702
+2,109
+4% +$22.9K
BPMC
534
DELISTED
Blueprint Medicines
BPMC
$620K 0.01%
4,836
+213
+5% +$22.1K
QIPT
535
DELISTED
Quipt Home Medical
QIPT
$617K 0.01%
344,927
-3,281
-0.9% -$6.47K
SNY icon
536
Sanofi
SNY
$104B
$616K 0.01%
+12,755
New +$652K
OBT icon
537
Orange County Bancorp
OBT
$515M
$595K 0.01%
+23,025
New +$562K
KTCC icon
538
Key Tronic
KTCC
$45.2M
$569K 0.01%
199,108
-24,341
-11% -$64.6K
BIIB icon
539
Biogen
BIIB
$30.7B
$566K 0.01%
4,503
+52
+1% +$6.48K
ALNY icon
540
Alnylam Pharmaceuticals
ALNY
$29B
$544K 0.01%
1,668
+127
+8% +$35.1K
TWIN icon
541
Twin Disc
TWIN
$343M
$543K 0.01%
61,443
-49,423
-45% -$365K
MIND icon
542
MIND Technology
MIND
$45.8M
$512K 0.01%
60,708
-253,707
-81% -$1.62M
FTRE icon
543
Fortrea Holdings
FTRE
$1.81B
$497K 0.01%
100,677
-111,459
-53% -$599K
OVID icon
544
Ovid Therapeutics
OVID
$478M
$496K 0.01%
1,502,329
-230,536
-13% -$69.5K
NUVL
545
DELISTED
Nuvalent
NUVL
$420K 0.01%
5,504
+196
+4% +$14.3K
ATLC icon
546
Atlanticus Holdings
ATLC
$1.48B
$406K 0.01%
7,423
-48,062
-87% -$2.49M
ELUT icon
547
Elutia
ELUT
$37.1M
$387K 0.01%
195,399
-86,282
-31% -$174K
VSTM icon
548
Verastem
VSTM
$605M
$374K 0.01%
90,203
+62,979
+231% +$395K
ADV icon
549
Advantage Solutions
ADV
$375M
$366K 0.01%
11,103
+955
+9% +$31.5K
POR icon
550
Portland General Electric
POR
$5.64B
$307K 0.01%
7,555
-22,055
-74% -$925K

Similar funds

Kennedy Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Kennedy Capital Management held 691 positions worth $4.19B, up 0.2% from $4.19B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Kennedy Capital Management withdrew a net $236M in Q2 2025, closing 110 positions and reducing 294 holdings. Its most notable exit was Columbia Banking Systems, an estimated $14.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Kennedy Capital Management opened a new position in Genpact worth $15.3M.

  • Kennedy Capital Management's largest Q2 2025 buy was Genpact: 347,353 shares worth $15.3M.
  • Kennedy Capital Management added most to Mercury Systems in Q2 2025, an estimated $8.73M increase.
  • Kennedy Capital Management's biggest Q2 2025 reduction was Hexcel, cutting an estimated $21.3M.
  • Kennedy Capital Management fully exited Columbia Banking Systems in Q2 2025, selling an estimated $14.4M.
  • Kennedy Capital Management's ten largest holdings make up 9.1% of its $4.19B portfolio in Q2 2025.
  • Kennedy Capital Management opened 49 new positions and closed 110 in Q2 2025.
  • Kennedy Capital Management's portfolio value rose 0.2% quarter-over-quarter to $4.19B.

Based on Kennedy Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.